Global Clinical Trial Management Systems Market

Report Scope:

This report examines the current and forecasted market potential for clinical trial management systems. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for clinical trial management systems based on the product, deployment and delivery mode.

The clinical trial management systems product market is segmented into software and services. The clinical trial management systems deployment market is segmented into enterprise-based CTMS and site-based CTMS. The clinical trial management systems delivery market is segmented into web-based, cloud-based and on-premises services.

The clinical trial management systems market has been geographically segmented into Europe, North America, the Asia-Pacific (APAC) region and the Rest of the World (RoW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India and China are regional segments. For market estimates, data are provided for 2020 as the base year, and then forecast form 2021 through year-end 2026. Estimated values are based on clinical trial management systems companies total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

- 32 tables
- An overview of the global markets for clinical trial management systems
- Estimation of the market size and analyses of market trends, with data from 2019 to 2020, estimates for 2021 and projection of CAGR through 2026
- Quantification of clinical trial management systems market based on product type, deployment, delivery mode and region, and analysis of market drivers, restraints and other forces impacting the global market
- Highlights of the current and future market potential and insights into government initiatives, regulatory framework and reimbursement scenario
- Detailed description of the advanced technologies for clinical trial management systems and discussion on how they are advantageous to pharmaceuticals, biotech and other research-focused life sciences organizations
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Advarra, Calyx, DatStat, Medidata and Oracle
Summary:

The global market for clinical trial management systems was valued at REDACTED in 2020. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED, to reach REDACTED by 2026. The global market is mainly driven by the increasing adoption of CTMSs in clinical trials and the rise of research and development (R&D) expenses of CRO. The fast spread of the coronavirus COVID-19 is also seen as another primary driver in the need for CTMS platforms.

CTMS is a software system utilized to manage clinical trials in medical organizations. CTMS serves as a single centralized corporate web resource to support clinical trials across multiple sites. It is a project management tool that allows clinicians to set milestones and track progress, see each teams performance, schedule thematic visits, manage relationships between different team members, control costs and prepare reports. It seems that a CTMS can solve the problem of integration and consistency, as many modern solutions come with EDC support.

CTMS implementation allows clinical research organizations to increase efficiency and achieve high results by:
- Improving the quality of patient care in clinical trials.
- Improving research reports.
- Facilitating compliance with research billing rules.
- Optimizing research finance management.
- Helping to adhere to research execution procedures and workingwithin deadlines and timelines.

The implementation of CTMS will simplify many aspects of the clinical research process, allowing for faster and better results. The need to adopt patient-centric clinical trials has never been more acute for global pharmaceutical organizations. One of the greatest learnings from the COVID-19 pandemic was the tremendous potential held by digital technologies to enable remote and personalized clinical trials, also referred to as decentralized trials, to achieve trial continuity and operational efficiencies. With the advancement in technology, proactive guidance fromregulators and a surge in wearable and devices, the adoption of decentralized trials has slowly become a must-have rather than a good-to-have initiative.

With the use of CTMS healthcare systems, professionals can easily access centralized data, thereby reducing the number of delayed trials. It can also handle site recruitment and identification while simultaneously providing control and tracking over subjects databases and subject enrolment.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Highlights of the Market for Clinical Trial Management Systems
Chapter 3 Market Background
Introduction
Need for CTMS
CTMS
CTMS Features
CTMS Benefits
CTMS versus EDC
Chapter 4 Market Dynamics
Market Drivers
Increased Outsourcing of Clinical Trials
Growing Number of Clinical Trials
Rising R&D Expenditure of Biopharma Companies
Increasing Prevalence of Chronic Diseases
Market Restraints
Unreliable and Inaccurate Data
Complex and Poorly-Integrated Systems
Regulatory Barriers and Approval Delays
Chapter 5 Impact of the COVID-19 Pandemic
Introduction
Outbreak
Impact of COVID-19 on Clinical Trial Management Systems
Chapter 6 Market Breakdown by Product
Introduction
Software
Market Size and Forecast
Market Analysis
Services
Market Size and Forecast
Market Analysis
Chapter 7 Market Breakdown by Deployment
Introduction
Enterprise-Based CTMS
Market Size and Forecast
Market Analysis
Site-Based CTMS
Market Size and Forecast
Market Analysis
Chapter 8 Market Breakdown by Delivery Mode
Introduction
Web-Based
Market Size and Forecast
Market Analysis
Cloud-Based
Market Size and Forecast
Market Analysis
On-premise
Market Size and Forecast
Market Analysis
Chapter 9 Market Breakdown by Region
Introduction
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World
Chapter 10 Competitive Landscape
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches, Achievements and Partnerships
Chapter 11 Company Profiles
ADVARRA
BSI BUSINESS SYSTEMS INTEGRATION AG
CALYX
CLARIO
DATSTAT (R1 COMPANY)
DATATRAK INT
ENNOV
MEDIDATA SOLUTION INC. (DASSAULT SYSTEMES)
ORACLE
REALTIME SOFTWARE SOLUTIONS LLC
VEEVA SYSTEMS INC.

List Of Tables

List of Tables
Summary Table : Global Market for Clinical Trial Management Systems, by Product, Through 2026
Table 1 : Global Market for Clinical Trial Management Systems, by Product, Through 2026
Table 2 : Global Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 3 : Global Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 4 : Global Market for Clinical Trial Management Systems, by Region, Through 2026
Table 5 : North American Market for Clinical Trial Management Systems, by Country, Through 2026
Table 6 : North American Market for Clinical Trial Management Systems, by Product, Through 2026
Table 7 : North American Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 8 : North American Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 9 : European Market for Clinical Trial Management Systems, by Country, Through 2026
Table 10 : European Market for Clinical Trial Management Systems, by Product, Through 2026
Table 11 : European Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 12 : European Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 13 : Asia-Pacific Market for Clinical Trial Management Systems, by Country, Through 2026
Table 14 : Asia-Pacific Market for Clinical Trial Management Systems, by Product, Through 2026
Table 15 : Asia-Pacific Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 16 : Asia-Pacific Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 17 : RoW Market for Clinical Trial Management Systems, by Product, Through 2026
Table 18 : RoW Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 19 : RoW Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 20 : Global Manufacturer Market Shares of Clinical Trial Management Systems, 2020
Table 21 : Advarra: Clinical Trial Management Systems Product Portfolio
Table 22 : BSI Business Systems Integration AG: Clinical Trial Management Systems Product Portfolio
Table 23 : Calyx: Clinical Trial Management Systems Product Portfolio
Table 24 : Clario: Clinical Trial Management Systems Product Portfolio
Table 25 : DatStat: Clinical Trial Management Systems Product Portfolio
Table 26 : Datatrak Int.: Clinical Trial Management Systems Product Portfolio
Table 27 : Ennov: Clinical Trial Management Systems Product Portfolio
Table 28 : Medidata Solution Inc.: Clinical Trial Management Systems Product Portfolio
Table 29 : Oracle: Clinical Trial Management Systems Portfolio
Table 30 : RealTime Software Solutions LLC: Clinical Trial Management Systems Portfolio
Table 31 : Veeva Systems Inc.: Clinical Trial Management Systems Portfolio

List Of Figures

List of Figures
Summary Figure A : Global Market for Clinical Trial Management Systems, by Product, 2019-2026
Summary Figure B : Global Market Shares of Clinical Trial Management Systems, by Product, 2020
Figure 1 : Global Leading Causes of Death, 2019
Figure 2 : Global Market Shares of Clinical Trial Management Systems, by Product, 2020
Figure 3 : Global Software Market, 2020-2026
Figure 4 : Global Market for Clinical Trial Management Services, 2020-2026
Figure 5 : Global Market Shares of Clinical Trial Management Systems, by Deployment, 2020
Figure 6 : Global Market for Enterprise-Based Clinical Trial Management Systems, 2020-2026
Figure 7 : Global Market for Site-Based Clinical Trial Management Systems, 2020-2026
Figure 8 : Global Market Shares of Clinical Trial Management Systems, by Delivery Mode, 2020
Figure 9 : Global Market for Web-Based Clinical Trial Management Systems, 2020-2026
Figure 10 : Global Market for Cloud-Based Clinical Trial Management Systems, 2020-2026
Figure 11 : Global Market for On-premise Clinical Trial Management Systems, 2020-2026
Figure 12 : Global Market Shares of Clinical Trial Management Systems, by Region, 2020
Figure 13 : North American Clinical Trial Management Systems Market Shares, by Country, 2020
Figure 14 : U.S. Market for Clinical Trial Management Systems, 2020-2026
Figure 15 : Canadian Market for Clinical Trial Management Systems, 2020-2026
Figure 16 : European Market Shares of Clinical Trial Management Systems, by Country, 2020
Figure 17 : German Market for Clinical Trial Management Systems, 2020-2026
Figure 18 : U.K. Market for Clinical Trial Management Systems, 2020-2026
Figure 19 : French Market Shares of Clinical Trial Management Systems, 2020-2026
Figure 20 : Italian Market for Clinical Trial Management Systems, 2020-2026
Figure 21 : Spanish Market for Clinical Trial Management Systems, 2020-2026
Figure 22 : Rest of European Market for Clinical Trial Management Systems, 2020-2026
Figure 23 : Asia-Pacific for Market Shares of Clinical Trial Management Systems, by Country, 2020
Figure 24 : Japanese Market for Clinical Trial Management Systems, 2020-2026
Figure 25 : Chinese Market for Clinical Trial Management Systems, 2020-2026
Figure 26 : Indian Market Shares of Clinical Trial Management Systems, 2020-2026
Figure 27 : Rest of Asia-Pacific Market for Clinical Trial Management Systems, 2020-2026
Figure 28 : Rest of the World Market for Clinical Trial Management Systems, 2020-2026

Antimicrobial and Antibacterial Plastics: Global Markets

Report Scope:This report will cover the antimicrobial and antibacterial plastic industry. Definitive and detailed estimates and forecasts of the global market are provided, followed by a detailed analysis of relevant

USD 5500 View Report

Cholesterol Tests: Global Markets

Report Scope:This report is a comprehensive study of the global market for cholesterol testing. It describes the cholesterol tests market, which is segmented by product type and region. Based on

USD 5500 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available